Vascular Access Surgery Timing
Kidney360 · 2026-09 · 7 (9) · 2066-2074
DOI: 10.34067/kid.0000001180 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Kidney360, online erschienen am 27.03.2026. Verfasst von Boudewijn D C Heggen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leading the Change, Nierstichting.
Abstract (Originalsprache)
Key Points Only 32% of elderly patients with ESKD in Europe started hemodialysis with a functional fistula that was created on time. Vascular access was created early in 42% and late in 26% of patients, exposing these patients to unused fistulas or catheter dependency. Eventually, 90% of all patients after fistula creation started hemodialysis within the mean follow-up period of 30 months.
Background
Timing vascular access creation for older patients with ESKD is challenging. Autologous arteriovenous fistulas (AVF) are often created too early, leading to unused fistulas, or too late, necessitating central venous catheters (CVC). This study reports on vascular access creation in relation to hemodialysis initiation in European practice.
Methods
This study is a secondary analysis of the European Quality cohort: a prospective observational study that recruited patients aged ≥65 years with stage 4 or 5 CKD from six European countries. Patients were selected once their eGFR dropped below 15 ml/min per 1.73 m 2 , if they received a vascular access, and had at least 6 months of follow-up. Vascular access timing was categorized into three groups: early (no dialysis within 6 months after AVF creation), on time (dialysis initiated with an AVF within 6 months), and late (hemodialysis initiated with a CVC before or within 6 months after AVF creation).
Results
A total of 332 patients from the European Quality cohort were analyzed: 221 patients (67%) received an AVF as first vascular access and 111 patients (33%) a CVC. Among the latter, 53 patients (48%) underwent subsequent AVF creation, whereas for the remaining 58 patients, CVC was considered the intended vascular access strategy. At dialysis initiation, 158 patients (54%) used an AVF, while 136 patients (46%) used a CVC. AVF creation was on time in 88 of 274 patients (32%), early in 114 patients (42%), and late in 72 patients (26%). Despite high rates of early AVF creation, most fistulas were eventually used, as 90% of patients initiated hemodialysis within 3 years.
Conclusions
Only 32% of elderly patients with ESKD started hemodialysis with a functional AVF created on time (within the 6-month window), while 42% had early and 26% late creation. Clinical prediction tools are needed to optimize vascular access timing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
- ERA Registry, Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, The Netherlands.
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
- Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
ORCID-Profile: Boudewijn D C Heggen, Nicholas C Chesnaye, Friedo W Dekker, Merel van Diepen, Joris I Rotmans, Fergus J Caskey, Claudia Torino, Antonio Vilasi, Christiane Drechsler, Christoph Wanner, Maria Pippias, Kitty J Jager, Marie Evans, Mickaël Hiligsmann, Maarten G J Snoeijs
Förderung
- Leading the Change
- Nierstichting
Zitieren
APA
Heggen, B. D. C., Chesnaye, N. C., Dekker, F. W., van Diepen, M., Rotmans, J. I., Caskey, F. J., Torino, C., Vilasi, A., Szymczak, M., Drechsler, C., Wanner, C., Pippias, M., Jager, K. J., Evans, M., Hiligsmann, M., Schurink, G. W. H., Snoeijs, M. G. J., & EQUAL Study Investigators (2026). Vascular Access Surgery Timing. Kidney360, 7(9), 2066-2074. https://doi.org/10.34067/kid.0000001180
Vancouver
Heggen BDC, Chesnaye NC, Dekker FW, van Diepen M, Rotmans JI, Caskey FJ, et al. Vascular Access Surgery Timing. Kidney360. 2026;7(9):2066-2074. doi:10.34067/kid.0000001180
BibTeX
@article{Heggen2026,
author = {Heggen, Boudewijn D C and Chesnaye, Nicholas C and Dekker, Friedo W and van Diepen, Merel and Rotmans, Joris I and Caskey, Fergus J and Torino, Claudia and Vilasi, Antonio and Szymczak, Maciej and Drechsler, Christiane and Wanner, Christoph and Pippias, Maria and Jager, Kitty J and Evans, Marie and Hiligsmann, Mickaël and Schurink, Geert Willem H and Snoeijs, Maarten G J and EQUAL Study Investigators, EQUAL Study Investigators},
title = {Vascular Access Surgery Timing},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {9},
pages = {2066--2074},
doi = {10.34067/kid.0000001180}
}
EUVIMED